Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.
about
Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects.Potential Association of Triglyceride Glucose Index with Cardiac Autonomic Neuropathy in Type 2 Diabetes Mellitus Patients.Non-high-density lipoprotein fractions are strongly associated with the presence of metabolic syndrome independent of obesity and diabetes: a population-based study among Iranian adultsScreening and identification of apolipoprotein A-I as a potential hepatoblastoma biomarker in children, excluding inflammatory factors.Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic IndividualsSensitivity of various adiposity indices in identifying cardiometabolic diseases in Arab adults.Changes in Metabolic Health Status Over Time and Risk of Developing Type 2 Diabetes: A Prospective Cohort Study.Polyphenol-Rich Extract of Syzygium cumini Leaf Dually Improves Peripheral Insulin Sensitivity and Pancreatic Islet Function in Monosodium L-Glutamate-Induced Obese Rats.Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study.TyG Index Change Is More Determinant for Forecasting Type 2 Diabetes Onset Than Weight Gain.The cutoff values of indirect indices for measuring insulin resistance for metabolic syndrome in Korean children and adolescents.Visceral Adiposity and Anthropometric Indicators as Screening Tools of Metabolic Syndrome among Low Income Rural Adults in XinjiangChanges in triglycerides and high-density lipoprotein cholesterol may precede peripheral insulin resistance, with 2-h insulin partially mediating this unidirectional relationship: a prospective cohort study.The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes.The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.The Cut-off Values of Triglycerides and Glucose Index for Metabolic Syndrome in American and Korean Adolescents.Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia.Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults.Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans.A Novel Index Using Soluble CD36 Is Associated with the Prevalence of Type 2 Diabetes Mellitus: Comparison Study with Triglyceride-Glucose Index.InsuTAG: A novel physiologically relevant predictor for insulin resistance and metabolic syndrome.Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population.Clinical surrogate markers for predicting metabolic syndrome in middle-aged and elderly Chinese.Abdominal obesity adversely affects bone mass in children.Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.Are Thyroid Autoimmune Diseases Associated with Cardiometabolic Risks in a Population with Normal Thyroid-Stimulating Hormone?variants as genetic determinants of adiposity status, visceral adiposity indicators, and triglyceride-glucose (TyG) index-related parameters mediated by serum triglyceride levels
P2860
Q33765530-1DC49745-C700-4F43-BD39-1E35E2A1BF9DQ33770355-C01AF453-1A56-4AF4-A799-2F27E16A9F8BQ33776151-966F9CA7-A97A-4D68-9AA0-474737801DEEQ35690288-25DF5104-E802-42AE-8453-65487C1AD3D3Q35941451-EFE3E40E-DA51-4035-9B6E-4697D0CC9D86Q36051230-59E23650-B34A-4B24-BD02-6AE457B9ABACQ36195451-6DC3C95C-D011-4A37-9A1F-C5A4F035D28AQ36669997-A83589C6-B656-4803-8E80-B8029A71FCA8Q36815362-54E407D7-2AA1-40FD-9D2E-2E59F30657E0Q36993543-5FB4AD7E-04DB-47D8-A21D-81F83929F79EQ37355184-4E5E5DC7-4279-492A-A2F6-3F293D8E5B86Q37366857-E9228E4E-BC43-453C-B345-7355FE87263DQ37394438-3A77CF6F-96A3-4023-A76C-0BE34F265F2DQ37582683-8CC634DD-7585-4053-8611-9DC8A53F8E6EQ37595709-D1FD1246-8628-4AC6-A226-6D2F84DDA352Q37622306-40768444-BBEC-4961-9900-E1A0E954736CQ37727252-37FA590C-62A0-4599-BA4B-ACABD0BEFB90Q41497141-55BAA8EA-D752-4283-933B-5E515B645601Q42278845-B70C7A9B-0F98-499C-A881-6AF1AB3A990BQ42366431-E3D4BDE8-BA5E-478E-AADA-EC0DA2843392Q46135329-AD4185D9-EA7C-4CB8-90F4-28E1B7EF61DCQ47548078-E31D4A76-B20F-46D9-A2C6-316EC51255B4Q47782636-02FBBEFD-4CA4-42AC-8C35-14A515A1FDCDQ49873414-B93F7C77-ECBA-4116-85D3-6BC9EB2B7D7CQ55326372-A3D7DD8E-E26B-4F76-9336-0A74EDBAC92DQ58577194-ED784C1A-055C-4D2A-B1CC-98948534AE51Q58606554-89AB5C99-5AA3-44AC-AFC9-3E90A62A2959
P2860
Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical usefulness of lipid r ...... markers of insulin resistance.
@ast
Clinical usefulness of lipid r ...... markers of insulin resistance.
@en
Clinical usefulness of lipid r ...... markers of insulin resistance.
@nl
type
label
Clinical usefulness of lipid r ...... markers of insulin resistance.
@ast
Clinical usefulness of lipid r ...... markers of insulin resistance.
@en
Clinical usefulness of lipid r ...... markers of insulin resistance.
@nl
prefLabel
Clinical usefulness of lipid r ...... markers of insulin resistance.
@ast
Clinical usefulness of lipid r ...... markers of insulin resistance.
@en
Clinical usefulness of lipid r ...... markers of insulin resistance.
@nl
P2093
P2860
P1476
Clinical usefulness of lipid r ...... markers of insulin resistance.
@en
P2093
Muxun Zhang
Tingting Du
Xingxing Sun
Xinrong Zhou
Xuefeng Yu
P2860
P2888
P356
10.1186/S12933-014-0146-3
P407
P577
2014-10-20T00:00:00Z
P6179
1007934795